24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Direct Offering
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:17
The Midas of chips does it again with Astera Labs
14:45
There were many basic assumptions about women in the military. They didn’t hold after October 7
14:00
Automotive cyber startup C2A Security nets long-term agreement to protect Daimler Truck
13:10
Israeli high-tech shows signs of recovery with $1.6 billion raised in 105 rounds in Q1 of 2024
More stories
Buzz
Most popular
Daily
Weekly
1
From Yemen to Iran: Israel's new $1 billion spy plane is a war game changer
2
After fleeing Iran and an illustrious career in Israeli intelligence, Sanaz Yashar raises $30M for cyber startup
3
Legendary Israeli investor strikes gold again with Astera Labs
4
Cyber startup Coro nets $100 million Series D to make enterprise-grade security accessible to all
5
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
More news
Direct Offering
4 stories about Direct Offering
Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering
10.07.18
|
CTech
Jerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials
Biotech Company Compugen Down on Nasdaq Following $21 Million Direct Offering
17.06.18
|
Dror Reich
The Israel-based cancer immunotherapy company intends to use the proceedings for product development
OrbiMed Invests $16 Million in Derma Company Foamix
17.04.18
|
Lilach Baumer
Foamix is a clinical-stage company developing specialty foam-based treatments for skin conditions such as acne
Liver Treatment Company Galmed is Raising $6 Million in Direct Offering
04.04.18
|
Lilach Baumer
The company’s stock fell by 37% on Nasdaq since the beginning of the year, and by 66% since its Nasdaq listing in 2014
Please ensure Javascript is enabled for purposes of
website accessibility